Alpha 2.0
Login Register
» Articles » PMID: 21081607

What Makes an Orphan Drug?

Overview
Journal BMJ
Specialty General Medicine
Date 2010 Nov 18
PMID 21081607
Citations 5
Authors
Nigel Hawkes
Deborah Cohen
Affiliations
Soon will be listed here.
Citing Articles

Debates over orphan drug pricing: a meta-narrative literature review.

Hanchard M Orphanet J Rare Dis. 2025; 20(1):107.

PMID: 40055799 PMC: 11887186. DOI: 10.1186/s13023-025-03634-2.

Application of orphan drug designation to cancer treatments (2008-2017): a comprehensive and comparative analysis of the USA and EU.

Vokinger K, Kesselheim A BMJ Open. 2019; 9(10):e028634.

PMID: 31601584 PMC: 6797305. DOI: 10.1136/bmjopen-2018-028634.

Analysis of Health Technology Assessments of Orphan Drugs in Ireland from 2012 to 2017.

Usher C, McCullagh L, Tilson L, Barry M Pharmacoecon Open. 2019; 3(4):583-589.

PMID: 31073976 PMC: 6861405. DOI: 10.1007/s41669-019-0136-1.

[Rare diseases: laying out some challenges].

Cambios Rev Med. 2018; 16(1):8-9.

PMID: 29708234 PMC: 5920522.

Effectiveness, safety and costs of orphan drugs: an evidence-based review.

Onakpoya I, Spencer E, Thompson M, Heneghan C BMJ Open. 2015; 5(6):e007199.

PMID: 26109112 PMC: 4480037. DOI: 10.1136/bmjopen-2014-007199.